ALX Oncology Holdings Inc (ALXO)
1.41
+0.12
(+9.30%)
USD |
NASDAQ |
Nov 22, 16:00
1.405
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Shares Outstanding: 52.74M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 31, 2024 | 52.74M |
September 30, 2024 | 52.74M |
August 05, 2024 | 52.67M |
June 30, 2024 | 52.45M |
May 02, 2024 | 52.10M |
April 15, 2024 | 50.50M |
March 31, 2024 | 50.28M |
February 29, 2024 | 50.15M |
December 31, 2023 | 49.95M |
November 06, 2023 | 49.82M |
October 10, 2023 | 49.82M |
September 30, 2023 | 41.15M |
August 03, 2023 | 41.15M |
June 30, 2023 | 40.99M |
May 04, 2023 | 40.87M |
April 19, 2023 | 40.86M |
March 31, 2023 | 40.86M |
March 02, 2023 | 40.86M |
December 31, 2022 | 40.86M |
November 01, 2022 | 40.76M |
September 30, 2022 | 40.75M |
August 02, 2022 | 40.75M |
Date | Value |
---|---|
June 30, 2022 | 40.75M |
May 02, 2022 | 40.68M |
April 18, 2022 | 40.68M |
March 31, 2022 | 40.66M |
February 22, 2022 | 40.63M |
December 31, 2021 | 40.59M |
November 08, 2021 | 40.50M |
September 30, 2021 | 40.49M |
August 06, 2021 | 40.34M |
June 30, 2021 | 40.33M |
May 11, 2021 | 40.23M |
April 23, 2021 | 40.23M |
March 31, 2021 | 40.21M |
March 12, 2021 | 40.13M |
December 31, 2020 | 39.84M |
November 06, 2020 | 37.11M |
September 30, 2020 | 37.11M |
August 21, 2020 | 36.97M |
July 21, 2020 | 36.49M |
July 17, 2020 | 35.21M |
June 26, 2020 | 34.71M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
34.71M
Minimum
Jun 26 2020
52.74M
Maximum
Sep 30 2024
42.72M
Average
40.75M
Median
Aug 02 2022
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
Neurocrine Biosciences Inc | 101.25M |
Eton Pharmaceuticals Inc | 25.84M |
Verve Therapeutics Inc | 84.66M |
Immuneering Corp | 31.05M |